✦ LIBER ✦

Modulation of transforming growth factor beta expression and induction of apoptosis by tamoxifen in ER positive and ER negative breast cancer cells

✍ Scribed by Benson, JR; Baum, M

Book ID: 109837297
Publisher: Nature Publishing Group
Year: 1996
Tongue: English
Weight: 462 KB
Volume: 74
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1996.475

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capsaicin causes cell-cycle arrest and a

Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway

✍ Thoennissen, N H; O'Kelly, J; Lu, D; Iwanski, G B; La, D T; Abbassi, S; Leiter, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 912 KB

Expression of estrogen receptors in estr

Expression of estrogen receptors in estrogen receptor–negative human breast carcinoma cells: Modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor α (TGFα) gene expression

✍ M. Saeed Sheikh; Zhi-Ming Shao; Jian-Chyi Chen; Xiao-Su Li; Arif Hussain; Joseph 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 1005 KB

A number of studies suggest that an inverse correlation exists between the epidermal growth factor-receptor and the estrogen receptor expression in primary human breast carcinoma as well as in established human breast carcinoma cell lines. Recent studies suggest that the epidermal growth factor-rece

Induction of fibronectin gene expression

Induction of fibronectin gene expression by transforming growth factor beta-1 is attenuated in bronchial epithelial cells by ADP-ribosyltransferase inhibitors

✍ Joe D. Beckmann; Mary Illig; Debra Romberger; Stephen I. Rennard 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 836 KB

Transforming growth factor-beta (TGF-P) exerts several effects on cultured airway epithelial cells including inhibition of proliferation and stimulation of fibronectin gene expression. ADP-ribosylation is one potential regulatory mechanism of gene expression by TGF-P. We tested this possibility by e

Thrombospondin and transforming growth f

Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells

✍ Juan P. Arnoletti; Daniel Albo; Mark S. Granick; Mark P. Solomon; Analia Castigl 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 860 KB

Inhibition of proliferation and inductio

Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level

✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant

Transforming growth factor-β1-dependent

Transforming growth factor-β1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells

✍ Kiyoshi Wakahara; Hiroshi Kobayashi; Tatsuo Yagyu; Hidenori Matsuzaki; Toshiharu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

## Abstract The net balance between urokinase‐type plasminogen activator (uPA) and plasminogen activator inhibitor type‐1 (PAI‐1) has been implicated in tumor cell invasion and metastasis. To elucidate the mechanism of the transforming growth factor‐β1 (TGF‐β1)‐dependent up‐regulation of PAI‐1 expr